These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1875397)

  • 1. Adherence of Serratia marcescens in the pathogenesis of urinary tract infections in diabetic mice.
    Obana Y; Shibata K; Nishino T
    J Med Microbiol; 1991 Aug; 35(2):93-7. PubMed ID: 1875397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fimbrial adhesins of Serratia marcescens isolated from urinary tract infections: description and properties.
    Leranoz S; Orús P; Berlanga M; Dalet F; Viñas M
    J Urol; 1997 Feb; 157(2):694-8. PubMed ID: 8996400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The virulence of Enterobacter cloacae and Serratia marcescens in experimental bladder infection in diabetic mice.
    Obana Y; Nishino T
    J Med Microbiol; 1989 Oct; 30(2):105-9. PubMed ID: 2677380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uropathogenic Serratia marcescens of hospital origin: analysis of the adhesion mechanism of 2 strains].
    Padilla C; Brevis P; Padilla R
    Rev Med Chil; 1989 Jun; 117(6):629-35. PubMed ID: 2519411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serratia marcescens internalization and replication in human bladder epithelial cells.
    Hertle R; Schwarz H
    BMC Infect Dis; 2004 Jun; 4():16. PubMed ID: 15189566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemagglutination (fimbriae) and hydrophobicity in adherence of Serratia marcescens to urinary tract epithelium and contact lenses.
    Parment PA; Svanborg-Ede'n C; Chaknis MJ; Sawant AD; Hagberg L; Wilson LA; Ahearn DG
    Curr Microbiol; 1992 Aug; 25(2):113-8. PubMed ID: 1369499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fimbria-mediated adherence of Serratia marcescens strain US5 to human urinary bladder surface.
    Yamamoto T; Ariyoshi A; Amako K
    Microbiol Immunol; 1985; 29(7):677-81. PubMed ID: 2868402
    [No Abstract]   [Full Text] [Related]  

  • 9. Prodigiosin is not a determinant factor in lysis of Leishmania (Viannia) braziliensis after interaction with Serratia marcescens D-mannose sensitive fimbriae.
    Moraes CS; Seabra SH; Albuquerque-Cunha JM; Castro DP; Genta FA; de Souza W; Brazil RP; Garcia ES; Azambuja P
    Exp Parasitol; 2009 Jun; 122(2):84-90. PubMed ID: 19303010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania (Leishmania) chagasi interactions with Serratia marcescens: ultrastructural studies, lysis and carbohydrate effects.
    Moraes CS; Seabra SH; Castro DP; Brazil RP; de Souza W; Garcia ES; Azambuja P
    Exp Parasitol; 2008 Apr; 118(4):561-8. PubMed ID: 18206142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of insulin on the incidence of experimental Serratia marcescens cystitis in diabetic mice--relationship between insulin therapy and urea nitrogen content].
    Obana Y; Nishino T
    Kansenshogaku Zasshi; 1989 Jul; 63(7):708-13. PubMed ID: 2693544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quorum quelling efficacy of marine cyclic dipeptide -cyclo(L-leucyl-L-prolyl) against the uropathogen Serratia marcescens.
    Gowrishankar S; Pandian SK; Balasubramaniam B; Balamurugan K
    Food Chem Toxicol; 2019 Jan; 123():326-336. PubMed ID: 30419322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pili mediated agglutination of Serratia marcescens in human urine.
    Amako K; Ohshima H; Yasunaka K; Kono K
    Microbiol Immunol; 1981; 25(10):981-92. PubMed ID: 6118812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of the interaction of Serratia marcescens pili and human urinary mucin].
    Kohno K
    Nihon Saikingaku Zasshi; 1984 Mar; 39(2):85-102. PubMed ID: 6146729
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental urinary tract infection caused by Escherichia coli in diabetic mouse--uroepithelial colonization and polymorphonuclear leukocyte function].
    Kishi M
    Hinyokika Kiyo; 1992 Sep; 38(9):991-8. PubMed ID: 1414765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to determine antipathogenic potential of phenolic and flavonoid compounds against urinary pathogen Serratia marcescens.
    Annapoorani A; Parameswari R; Pandian SK; Ravi AV
    J Microbiol Methods; 2012 Oct; 91(1):208-11. PubMed ID: 22759832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell-bound hemolysin of Serratia marcescens contributes to uropathogenicity.
    Marre R; Hacker J; Braun V
    Microb Pathog; 1989 Aug; 7(2):153-6. PubMed ID: 2687613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-infection with Serratia marcescens.
    TAYLOR G; KEANE PM
    J Clin Pathol; 1962 Mar; 15(2):145-7. PubMed ID: 13919957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence of Serratia marcescens, Serratia liquefaciens, Pseudomonas aeruginosa and Staphylococcus epidermidis to blood transfusion bags (CPD-SAGMAN sets).
    Parment PA; Gabriel M; Bruse GW; Stegall S; Ahearn DG
    Scand J Infect Dis; 1993; 25(6):721-4. PubMed ID: 8052811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.